S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LPTX Leap Therapeutics Inc

2.9201

0.0101 (0.35%)

Dec 26 2024 - Closed

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Leap Therapeutics (NASDAQ:LPTX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Leap Therapeutics Charts.

Leap Therapeutics (NASDAQ:LPTX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Leap Therapeutics Charts.

Leap Therapeutics Inc News

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
Tuesday 26 November 2024 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Leap Therapeutics Reports Third Quarter 2024 Financial Results
Wednesday 13 November 2024 (1 month ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 31 October 2024 (2 months ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 31 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (3 months ago) • Edgar (US Regulatory)

More Leap Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions